79
Views
4
CrossRef citations to date
0
Altmetric
Articles

RECOMBINANT HUMAN ERYTHROPOIETIN BETA THERAPY: An Effective Strategy to Reduce Transfusion Requirement in Children Receiving Anticancer Treatment

, MD, , MD, , MD, , MD, , MD & , MD
Pages 509-521 | Received 17 Aug 2007, Accepted 18 Apr 2008, Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Oguzhan Durmaz, Metin Demirkaya & Betül Sevinir. (2011) Recombinant Human Erythropoietin β: The Effect of Weekly Dosing on Anemia, Quality of Life, and Long-Term Outcomes in Pediatric Cancer Patients. Pediatric Hematology and Oncology 28:6, pages 461-468.
Read now

Articles from other publishers (3)

Pervin KÜÇÜKTAŞ, İdris ŞAHİN, Emel ÇALIŞKAN & Özge KILINÇEL. (2019) Düzce Üniversitesi Sağlık Uygulama Ve Araştırma Merkezi’nde Kan Ve Kan Bileşenlerinin Kliniklere Göre Kullanımlarının DeğerlendirilmesiEvaluation Of Use Of Blood And Blood Components By Clinics At Düzce University Health Application And Research Center. Kocaeli Üniversitesi Sağlık Bilimleri Dergisi 5:1, pages 25-28.
Crossref
Anurag K. Agrawal & Jeffrey D. Hord. 2015. Supportive Care in Pediatric Oncology. Supportive Care in Pediatric Oncology 247 260 .
Yuan-Yuan Liu, Zhen-Jue She & Ming-Hui Yao. (2010) Erythropoietin inhibits γ-irradiation-induced apoptosis by upregulation of Bcl-2 and decreasing the activation of caspase 3 in human UT-7/erythropoietin cell line. Clinical and Experimental Pharmacology and Physiology 37:5-6, pages 624-629.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.